Press Releases

WASHINGTON, May 10, 2024 (GLOBE NEWSWIRE) -- The Mark Cuban Foundation, in partnership with Booz Allen Hamilton is bringing back the only artificial intelligence (AI) camp of its kind, free of charge, to high school students in the Washington, D.C. area. With a custom and highly relevant curriculum focused on teaching students about the latest developments in the world of AI and Generative AI, the camp will provide the tools to make these technologies work for them... (continue reading...)

ROCHESTER, N.H.--(BUSINESS WIRE)-- The Board of Directors of Albany International Corp. (NYSE: AIN) today declared a quarterly dividend of $0.26 per share on the Company’s Class A Common Stock.

The dividend is payable July 8, 2024, to shareholders of record on June 7, 2024.

About Albany International Corp.

Albany International is a leading developer and manufacturer of engineered components, using advanced materials processing and automation capabilities,... (continue reading...)

FORT WORTH, Texas, May 10, 2024 (GLOBE NEWSWIRE) -- Tandy Leather Factory, Inc. (Nasdaq: TLF) today announced the Company’s financial results for the first fiscal quarter of 2024.

Highlights from First Quarter 2024:

• Revenues were $19.3 million, down 5.3% from 2023
• Generated operating income of $0.7 million
• Net income of $0.5 million, down from $0.7 million in 2023
• Gross margins of 56.7%, down from 58.1% in 2023
• Operating expenses $10.3 million, down 5.2% from... (continue reading...)

GLEN ALLEN, Va., May 10, 2024 /PRNewswire/ -- The Board of Directors of Hamilton Beach Brands Holding Company (NYSE: HBB) has approved a 4.5% increase in the Company's regular quarterly cash dividend, raising the quarterly amount from $0.11 per share to $0.115 per share.

The dividend is payable on both the Class A and Class B Common Stock and will be paid June 14, 2024, to stockholders of record at the close of business on May 31, 2024.

About Hamilton Beach Brands... (continue reading...)

TORONTO, ON / ACCESSWIRE / May 10, 2024 / Edesa Biotech, Inc. (Nasdaq: EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three and six months ended March 31, 2024 and provided an update on its business.

During the quarter, the company expanded site selection activities for a Phase 3 study of its ARDS (Acute Respiratory Distress Syndrome) drug... (continue reading...)